\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ vitals\\ normal\\.\\ \\ no\\ respiratory\\ complaints\\.\ \(0\)\
\-\ the\\ patient\\ denied\\ pulmonary\\ symptoms\\.\\ \\ the\\ patient\\ did\\ complain\\ of\\ persistent\\ headaches\\ in\\ the\\ days\\ following\\ the\\ embolization\\ procedure\\.\ \(0\)\
\-\ chest\\ radiograph\\ demonstrates\\ branching\\ opacity\\ in\\ a\\ bronchovascular\\ distribution\\ in\\ the\\ right\\ middle\\ lobe\\.\ \(0\)\
\-\ review\\ of\\ prior\\ imaging\\ demonstrates\\ presence\\ of\\ a\\ vein\\ of\\ galen\\ malformation\\ with\\ recent\\ embolization\\ treatment\\ with\\ onyx\\.\ \(0\)\
\-\ vein\\ of\\ galen\\ malformation\\,\\ onyx\\ embolization\\;\\ and\\,\\ \\ embolization\\ into\\ branches\\ of\\ the\\ pulmonary\\ arteries\\.\ \(0\)\
\-\ without\\ the\\ provided\\ history\\,\\ this\\ radiographic\\ finding\\ is\\ concerning\\ for\\ aspiration\\ of\\ contrast\\ or\\ other\\ radio\\-opaque\\ material\\.\ \(0\)\
\-\ 8\\ year\\ old\\ girl\\ status\\ post\\ vein\\ of\\ galen\\ aneurysm\\ onyx\\ embolization\\ treatment\\.\\ \\ a\\ chest\\ x\\-ray\\ was\\ ordered\\ to\\ confirm\\ endotracheal\\ tube\\ placement\\ following\\ an\\ uneventful\\ post\\-operative\\ course\\.\ \(0\)\
\-\ this\\ radiographic\\ finding\\ was\\ noted\\ immediately\\ following\\ embolization\\ of\\ the\\ patient\\'s\\ vein\\ of\\ galen\\ \\(vog\\)\\ malformation\\ using\\ the\\ liquid\\ embolic\\ agent\\,\\ onyx\\.\\ \\ onyx\\ is\\ a\\ relatively\\ new\\ material\\ composed\\ of\\ an\\ ethylene\\-vinyl\\ alcohol\\ copolymer\\,\\ dmso\\,\\ and\\ tantalum\\.\\ \\ tantalum\\ provides\\ the\\ radio\\-opaque\\ property\\ for\\ intraoperative\\ visualization\\ and\\ accounts\\ for\\ the\\ appearance\\ on\\ this\\ patients\\ chest\\ radiograph\\.\\ \\ \ \(0\)\
\-\ relatively\\ little\\ formal\\ analysis\\ of\\ the\\ efficacy\\ and\\ safety\\ of\\ the\\ use\\ of\\ onyx\\ in\\ the\\ treatment\\ intracerebral\\ avm\\'s\\ has\\ been\\ conducted\\.\\ \\ a\\ study\\ by\\ van\\ rooij\\ et\\ al\\,\\ revealed\\ an\\ average\\ of\\ 75\\%\\ reduction\\ in\\ the\\ volume\\ of\\ avm\\'s\\ with\\ a\\ complication\\ rate\\ of\\ 13\\.6\\%\\.\\ \\ jahan\\ et\\ al\\ reported\\ similar\\ numbers\\ of\\ 63\\%\\ and\\ 26\\%\\,\\ respectively\\.\\ \\ while\\ post\\-embolization\\ headaches\\ were\\ reported\\,\\ the\\ majority\\ of\\ collected\\ and\\ reported\\ problems\\ involved\\ hemorrhagic\\ complications\\.\\ \\ such\\ complications\\ are\\ postulated\\ to\\ be\\ secondary\\ to\\ physiologic\\ changes\\ in\\ the\\ regional\\ cerebral\\ blood\\ flow\\ surrounding\\ the\\ perinidal\\ tissues\\.\\ \\ proposed\\ solutions\\ to\\ such\\ complications\\ include\\ possible\\ staged\\ emobolization\\ procedures\\ such\\ to\\ produce\\ less\\-drastic\\ changes\\ in\\ flow\\ dynamics\\.\ \(0\)\
\-\ while\\ no\\ instances\\ of\\ symptomatic\\ pulmonary\\ embolism\\(pe\\)\\ were\\ reported\\ in\\ these\\ investigations\\,\\ symptomatic\\ pulmonary\\ embolism\\ is\\ a\\ serious\\ potential\\ consequence\\ of\\ accidental\\ peripheral\\ emobolization\\.\\ \\ as\\ in\\ this\\ patient\\â\\€\\™s\\ case\\,\\ the\\ risk\\ of\\ symptomatic\\ pe\\ is\\ likely\\ lower\\ if\\ only\\ small\\ volumes\\ of\\ the\\ embolic\\ agent\\ migrate\\ to\\ the\\ pulmonary\\ vasculature\\.\\ \\ this\\ is\\ a\\ risk\\ that\\ may\\ be\\ mitigated\\ with\\ careful\\ technique\\ and\\ intraoperative\\ observation\\.\ \(0\)\
\-\ references\ \(24\)\
\-\ van\\ rooij\\ et\\ al\\,\\ brain\\ avm\\ embolization\\ with\\ onyx\\.\\ american\\ journal\\ of\\ neuroradiology\\.\\ 28\\:172\\-177\\,\\ january\\ 2007\ \(0\)\
\-\ jahan\\ et\\ al\\,\\ embolization\\ of\\ arteriovenous\\ malformations\\ with\\ onyx\\:\\ clinicopathological\\ experience\\ in\\ 23\\ patients\\.\ \(0\)\
\-\ neurosurgery\\.\\ 48\\(5\\)\\:984\\-997\\,\\ may\\ 2001\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ onyx\\:\\ 0\\.13416205982567236\ \(0\)\
\-\ embolization\\:\\ 0\\.07185980166167079\ \(0\)\
\-\ galen\\:\\ 0\\.05301200401625334\ \(0\)\
\-\ tantalum\\:\\ 0\\.039799180243641076\ \(0\)\
\-\ jahan\\:\\ 0\\.039799180243641076\ \(0\)\
\-\ rooij\\:\\ 0\\.03666984760002958\ \(0\)\
\-\ emobolization\\:\\ 0\\.03666984760002958\ \(0\)\
\-\ radio\\-opaque\\:\\ 0\\.03483930535123426\ \(0\)\
\-\ al\\:\\ 0\\.0327093595763096\ \(0\)\
\-\ et\\:\\ 0\\.03157921833067523\ \(0\)\
\-\ pulmonary\\:\\ 0\\.028177768738375436\ \(0\)\
\-\ reported\\:\\ 0\\.028127086686914778\ \(0\)\
\-\ vein\\:\\ 0\\.027918133833084578\ \(0\)\
\-\ van\\:\\ 0\\.02757321996778459\ \(0\)\
\-\ avm\\:\\ 0\\.027566047148554727\ \(0\)\
\-\ intraoperative\\:\\ 0\\.02545130742039978\ \(0\)\
\-\ agent\\:\\ 0\\.024755367556619837\ \(0\)\
\-\ embolic\\:\\ 0\\.02349706777120665\ \(0\)\
\-\ malformation\\:\\ 0\\.023081354305912277\ \(0\)\
\-\ symptomatic\\:\\ 0\\.02299085840650708\ \(0\)\
\-\ complications\\:\\ 0\\.02293119274274531\ \(0\)\
\-\ ethylene\\-vinyl\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ property\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ 13\\.6\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ perinidal\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ solutions\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ less\\-drastic\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ mitigated\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ 28\\:172\\-177\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ \\:984\\-997\\:\\ 0\\.019899590121820538\ \(0\)\
\-\ embolism\\:\\ 0\\.01887489587240118\ \(0\)\
\-\ vog\\:\\ 0\\.01833492380001479\ \(0\)\
\-\ copolymer\\:\\ 0\\.01833492380001479\ \(0\)\
\-\ dmso\\:\\ 0\\.01833492380001479\ \(0\)\
\-\ such\\:\\ 0\\.018090289773188616\ \(0\)\
\-\ \\%\\:\\ 0\\.01799838404827095\ \(0\)\
\-\ dynamics\\:\\ 0\\.01741965267561713\ \(0\)\
\-\ clinicopathological\\:\\ 0\\.01741965267561713\ \(0\)\
\-\ pe\\:\\ 0\\.017330856350094462\ \(0\)\
\-\ material\\:\\ 0\\.01723840248398367\ \(0\)\
\-\ migrate\\:\\ 0\\.016770257478209045\ \(0\)\
\-\ relatively\\:\\ 0\\.016507734197525818\ \(0\)\
\-\ following\\:\\ 0\\.016424002868405067\ \(0\)\
\-\ formal\\:\\ 0\\.01585498635381138\ \(0\)\
\-\ post\\-embolization\\:\\ 0\\.01585498635381138\ \(0\)\
\-\ postulated\\:\\ 0\\.01585498635381138\ \(0\)\
\-\ collected\\:\\ 0\\.01550701642192141\ \(0\)\
\-\ staged\\:\\ 0\\.0152055911564033\ \(0\)\
\-\ investigations\\:\\ 0\\.0152055911564033\ \(0\)\
\-\ numbers\\:\\ 0\\.01493971522941372\ \(0\)\
\-\ headaches\\:\\ 0\\.014746918009351143\ \(0\)\
\-\ radiographic\\:\\ 0\\.014642728631100376\ \(0\)\
\-\ bronchovascular\\:\\ 0\\.01448673397554882\ \(0\)\
\-\ safety\\:\\ 0\\.01448673397554882\ \(0\)\
\-\ consequence\\:\\ 0\\.01448673397554882\ \(0\)\
\-\ instances\\:\\ 0\\.014109636718972822\ \(0\)\
\-\ accidental\\:\\ 0\\.014109636718972822\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.014109636718972822\ \(0\)\
\-\ risk\\:\\ 0\\.013973844909070367\ \(0\)\
\-\ chest\\:\\ 0\\.01384692325095385\ \(0\)\
\-\ intracerebral\\:\\ 0\\.013786609983892296\ \(0\)\
\-\ liquid\\:\\ 0\\.013504074672483705\ \(0\)\
\-\ efficacy\\:\\ 0\\.013504074672483705\ \(0\)\
\-\ endotracheal\\:\\ 0\\.013137214786484214\ \(0\)\
\-\ january\\:\\ 0\\.013137214786484214\ \(0\)\
\-\ physiologic\\:\\ 0\\.013027078975718\ \(0\)\
\-\ volumes\\:\\ 0\\.012922067653743074\ \(0\)\
\-\ \\'s\\:\\ 0\\.012758780711289244\ \(0\)\
\-\ flow\\:\\ 0\\.012749678902295784\ \(0\)\
\-\ conducted\\:\\ 0\\.01272565371019989\ \(0\)\
\-\ proposed\\:\\ 0\\.01272565371019989\ \(0\)\
\-\ uneventful\\:\\ 0\\.012459777783210313\ \(0\)\
\-\ finding\\:\\ 0\\.0124336862529954\ \(0\)\
\-\ serious\\:\\ 0\\.012377683778309919\ \(0\)\
\-\ radiograph\\:\\ 0\\.012288707241179966\ \(0\)\
\-\ branching\\:\\ 0\\.012221943662086551\ \(0\)\
\-\ regional\\:\\ 0\\.012221943662086551\ \(0\)\
\-\ accounts\\:\\ 0\\.012147926003343908\ \(0\)\
\-\ while\\:\\ 0\\.012138371286014958\ \(0\)\
\-\ complain\\:\\ 0\\.012076258512791808\ \(0\)\
\-\ careful\\:\\ 0\\.012076258512791808\ \(0\)\
\-\ provides\\:\\ 0\\.011939408350677961\ \(0\)\
\-\ composed\\:\\ 0\\.01181038258580223\ \(0\)\
\-\ treatment\\:\\ 0\\.011712981667726097\ \(0\)\
\-\ average\\:\\ 0\\.01125705875277066\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.011160987388394147\ \(0\)\
\-\ respectively\\:\\ 0\\.011114442722022283\ \(0\)\
\-\ technique\\:\\ 0\\.011114442722022283\ \(0\)\
\-\ changes\\:\\ 0\\.011056650005575893\ \(0\)\
\-\ journal\\:\\ 0\\.010937305892583243\ \(0\)\
\-\ 2007\\:\\ 0\\.010895111461404568\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.010853691283823989\ \(0\)\
\-\ this\\:\\ 0\\.010848049811671931\ \(0\)\
\-\ malformations\\:\\ 0\\.010773063557859928\ \(0\)\
\-\ 63\\:\\ 0\\.01069521665927941\ \(0\)\
\-\ produce\\:\\ 0\\.01069521665927941\ \(0\)\
\-\ experience\\:\\ 0\\.010583259681538164\ \(0\)\
\-\ branches\\:\\ 0\\.010547141529514595\ \(0\)\
\-\ little\\:\\ 0\\.01047659402724799\ \(0\)\
\-\ vasculature\\:\\ 0\\.01047659402724799\ \(0\)\
\-\ procedures\\:\\ 0\\.010442130207539665\ \(0\)\
\-\ 2001\\:\\ 0\\.010245716263996485\ \(0\)\
\-\ visualization\\:\\ 0\\.010183867563797579\ \(0\)\
\-\ concerning\\:\\ 0\\.010123668360451844\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.010123668360451844\ \(0\)\
\-\ patients\\:\\ 0\\.0099845354373184\ \(0\)\
\-\ observation\\:\\ 0\\.00989774633210651\ \(0\)\
\-\ 75\\:\\ 0\\.009871031980758874\ \(0\)\
\-\ confirm\\:\\ 0\\.009818533420568655\ \(0\)\
\-\ analysis\\:\\ 0\\.009818533420568655\ \(0\)\
\-\ alcohol\\:\\ 0\\.009717063019073697\ \(0\)\
\-\ immediately\\:\\ 0\\.0095729287707971\ \(0\)\
\-\ in\\:\\ 0\\.009512352824836454\ \(0\)\
\-\ majority\\:\\ 0\\.009481710851298506\ \(0\)\
\-\ complication\\:\\ 0\\.009459470904474552\ \(0\)\
\-\ 48\\:\\ 0\\.00943744793620059\ \(0\)\
\-\ denied\\:\\ 0\\.00939403628399317\ \(0\)\
\-\ potential\\:\\ 0\\.009289024962018243\ \(0\)\
\-\ vitals\\:\\ 0\\.009228285790641439\ \(0\)\
\-\ american\\:\\ 0\\.009188682382851575\ \(0\)\
\-\ 23\\:\\ 0\\.009169138223160572\ \(0\)\
\-\ \\,\\:\\ 0\\.009166255040088738\ \(0\)\
\-\ volume\\:\\ 0\\.009111500972584579\ \(0\)\
\-\ aspiration\\:\\ 0\\.00909261101847506\ \(0\)\
\-\ reduction\\:\\ 0\\.00909261101847506\ \(0\)\
\-\ ordered\\:\\ 0\\.009073877829277103\ \(0\)\
\-\ opacity\\:\\ 0\\.009018593359732418\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.009000462046646042\ \(0\)\
\-\ 26\\:\\ 0\\.008929358960733241\ \(0\)\
\-\ problems\\:\\ 0\\.008929358960733241\ \(0\)\
\-\ were\\:\\ 0\\.008759757727719733\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.008696780572701108\ \(0\)\
\-\ distribution\\:\\ 0\\.008681049942190738\ \(0\)\
\-\ may\\:\\ 0\\.008461979092090852\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008427183754641923\ \(0\)\
\-\ complaints\\:\\ 0\\.00837375383762058\ \(0\)\
\-\ using\\:\\ 0\\.00837375383762058\ \(0\)\
\-\ review\\:\\ 0\\.008360114301602608\ \(0\)\
\-\ provided\\:\\ 0\\.008319683316125112\ \(0\)\
\-\ tube\\:\\ 0\\.00812772610915917\ \(0\)\
\-\ involved\\:\\ 0\\.00809121852621199\ \(0\)\
\-\ procedure\\:\\ 0\\.008079179370511396\ \(0\)\
\-\ references\\:\\ 0\\.00801992829585014\ \(0\)\
\-\ respiratory\\:\\ 0\\.008008262448991353\ \(0\)\
\-\ an\\:\\ 0\\.008002245130596365\ \(0\)\
\-\ arteries\\:\\ 0\\.007985110078410792\ \(0\)\
\-\ tissues\\:\\ 0\\.00791704452949276\ \(0\)\
\-\ placement\\:\\ 0\\.007829369962187424\ \(0\)\
\-\ patient\\:\\ 0\\.0077344643875068885\ \(0\)\
\-\ persistent\\:\\ 0\\.007693784768637425\ \(0\)\
\-\ aneurysm\\:\\ 0\\.00762401606104583\ \(0\)\
\-\ use\\:\\ 0\\.00762401606104583\ \(0\)\
\-\ similar\\:\\ 0\\.0075658840156679185\ \(0\)\
\-\ rate\\:\\ 0\\.007518558669245695\ \(0\)\
\-\ course\\:\\ 0\\.00727885201682989\ \(0\)\
\-\ 8\\:\\ 0\\.007212454984761508\ \(0\)\
\-\ a\\:\\ 0\\.007162073170539074\ \(0\)\
\-\ middle\\:\\ 0\\.007054534920186089\ \(0\)\
\-\ presence\\:\\ 0\\.007001773405095099\ \(0\)\
\-\ peripheral\\:\\ 0\\.0069795334582711446\ \(0\)\
\-\ did\\:\\ 0\\.006964827632038202\ \(0\)\
\-\ status\\:\\ 0\\.006885614720500346\ \(0\)\
\-\ girl\\:\\ 0\\.006781890363408121\ \(0\)\
\-\ new\\:\\ 0\\.006721869022123156\ \(0\)\
\-\ cerebral\\:\\ 0\\.006682723480280069\ \(0\)\
\-\ of\\:\\ 0\\.006574706591308602\ \(0\)\
\-\ the\\:\\ 0\\.006553577830194451\ \(0\)\
\-\ possible\\:\\ 0\\.006496573857526122\ \(0\)\
\-\ recent\\:\\ 0\\.0064846931125051846\ \(0\)\
\-\ study\\:\\ 0\\.006346797645282075\ \(0\)\
\-\ is\\:\\ 0\\.006346397047231667\ \(0\)\
\-\ surrounding\\:\\ 0\\.00634123084506719\ \(0\)\
\-\ revealed\\:\\ 0\\.006190685981639036\ \(0\)\
\-\ post\\:\\ 0\\.006074119713481475\ \(0\)\
\-\ be\\:\\ 0\\.005949240285977106\ \(0\)\
\-\ days\\:\\ 0\\.0059121315940676685\ \(0\)\
\-\ brain\\:\\ 0\\.00580440524447576\ \(0\)\
\-\ only\\:\\ 0\\.0058000263171217505\ \(0\)\
\-\ to\\:\\ 0\\.005784218173042703\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.005765297380689516\ \(0\)\
\-\ 5\\:\\ 0\\.005643702985201271\ \(0\)\
\-\ s\\:\\ 0\\.005532206923509225\ \(0\)\
\-\ appearance\\:\\ 0\\.005516719134841177\ \(0\)\
\-\ likely\\:\\ 0\\.005440835137552271\ \(0\)\
\-\ include\\:\\ 0\\.005411181688555951\ \(0\)\
\-\ secondary\\:\\ 0\\.005392844168191439\ \(0\)\
\-\ blood\\:\\ 0\\.005265036281059367\ \(0\)\
\-\ been\\:\\ 0\\.005247843994275375\ \(0\)\
\-\ if\\:\\ 0\\.005234183823432585\ \(0\)\
\-\ lobe\\:\\ 0\\.00519035067251362\ \(0\)\
\-\ these\\:\\ 0\\.00501996544460009\ \(0\)\
\-\ prior\\:\\ 0\\.00495285050158547\ \(0\)\
\-\ for\\:\\ 0\\.004937526965977755\ \(0\)\
\-\ \\(\\:\\ 0\\.0048918401325769335\ \(0\)\
\-\ \\)\\:\\ 0\\.00483208369376956\ \(0\)\
\-\ symptoms\\:\\ 0\\.004807353220989027\ \(0\)\
\-\ physical\\:\\ 0\\.0047325175385580995\ \(0\)\
\-\ into\\:\\ 0\\.004589901507809722\ \(0\)\
\-\ \\;\\:\\ 0\\.004572056858809466\ \(0\)\
\-\ noted\\:\\ 0\\.004572056858809466\ \(0\)\
\-\ without\\:\\ 0\\.0045417904432464105\ \(0\)\
\-\ imaging\\:\\ 0\\.00451935400554312\ \(0\)\
\-\ was\\:\\ 0\\.004461749535953439\ \(0\)\
\-\ other\\:\\ 0\\.004446136678786565\ \(0\)\
\-\ small\\:\\ 0\\.004443736533591689\ \(0\)\
\-\ lower\\:\\ 0\\.0043382890956294865\ \(0\)\
\-\ contrast\\:\\ 0\\.004317778074058477\ \(0\)\
\-\ exam\\:\\ 0\\.0042375483971772866\ \(0\)\
\-\ case\\:\\ 0\\.004220100299926119\ \(0\)\
\-\ no\\:\\ 0\\.003884623705209038\ \(0\)\
\-\ has\\:\\ 0\\.0036223475631925006\ \(0\)\
\-\ that\\:\\ 0\\.0033317849403133705\ \(0\)\
\-\ and\\:\\ 0\\.003250726965818843\ \(0\)\
\-\ by\\:\\ 0\\.003211898201455699\ \(0\)\
\-\ normal\\:\\ 0\\.0030239558794562097\ \(0\)\
\-\ as\\:\\ 0\\.002917782180347918\ \(0\)\
\-\ history\\:\\ 0\\.0026641411686390143\ \(0\)\
\-\ are\\:\\ 0\\.002629512127606324\ \(0\)\
\-\ \\:\\:\\ 0\\.0025514104198434873\ \(0\)\
\-\ or\\:\\ 0\\.002260773699692342\ \(0\)\
\-\ year\\:\\ 0\\.002158251172173622\ \(0\)\
\-\ \\.\\:\\ 0\\.0020834942179029418\ \(0\)\
\-\ right\\:\\ 0\\.002035286025079947\ \(0\)\
\-\ old\\:\\ 0\\.001975021663345947\ \(0\)\
\-\ on\\:\\ 0\\.0016340654906668805\ \(0\)\
\-\ with\\:\\ 0\\.0015847066739036984\ \(0\)\
